nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—Prednisone—ankylosing spondylitis	0.418	1	CrCtD
Danazol—PGR—Betamethasone—ankylosing spondylitis	0.071	0.343	CbGbCtD
Danazol—PGR—Dexamethasone—ankylosing spondylitis	0.0413	0.2	CbGbCtD
Danazol—CYP19A1—Betamethasone—ankylosing spondylitis	0.0399	0.193	CbGbCtD
Danazol—CYP19A1—Dexamethasone—ankylosing spondylitis	0.0232	0.112	CbGbCtD
Danazol—Cortisone acetate—Methylprednisolone—ankylosing spondylitis	0.0137	0.0435	CrCrCtD
Danazol—Testolactone—Methylprednisolone—ankylosing spondylitis	0.0133	0.0422	CrCrCtD
Danazol—Testolactone—Betamethasone—ankylosing spondylitis	0.0131	0.0415	CrCrCtD
Danazol—Testolactone—Dexamethasone—ankylosing spondylitis	0.0131	0.0415	CrCrCtD
Danazol—Testolactone—Triamcinolone—ankylosing spondylitis	0.0128	0.0406	CrCrCtD
Danazol—Cortisone acetate—Prednisone—ankylosing spondylitis	0.0125	0.0397	CrCrCtD
Danazol—Cortisone acetate—Prednisolone—ankylosing spondylitis	0.0122	0.0387	CrCrCtD
Danazol—Testolactone—Prednisone—ankylosing spondylitis	0.0121	0.0385	CrCrCtD
Danazol—Fluoxymesterone—Betamethasone—ankylosing spondylitis	0.012	0.0382	CrCrCtD
Danazol—Fluoxymesterone—Dexamethasone—ankylosing spondylitis	0.012	0.0382	CrCrCtD
Danazol—Prednisone—Methylprednisolone—ankylosing spondylitis	0.0119	0.0378	CrCrCtD
Danazol—Testolactone—Prednisolone—ankylosing spondylitis	0.0119	0.0376	CrCrCtD
Danazol—Fluoxymesterone—Triamcinolone—ankylosing spondylitis	0.0118	0.0373	CrCrCtD
Danazol—Prednisone—Dexamethasone—ankylosing spondylitis	0.0117	0.0372	CrCrCtD
Danazol—Prednisone—Betamethasone—ankylosing spondylitis	0.0117	0.0372	CrCrCtD
Danazol—Prednisone—Triamcinolone—ankylosing spondylitis	0.0115	0.0363	CrCrCtD
Danazol—Fluoxymesterone—Prednisolone—ankylosing spondylitis	0.0109	0.0345	CrCrCtD
Danazol—Progesterone—Prednisolone—ankylosing spondylitis	0.0106	0.0336	CrCrCtD
Danazol—Prednisone—Prednisolone—ankylosing spondylitis	0.0106	0.0336	CrCrCtD
Danazol—Methyltestosterone—Prednisone—ankylosing spondylitis	0.0106	0.0336	CrCrCtD
Danazol—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.0103	0.0328	CrCrCtD
Danazol—Hydrocortisone—Methylprednisolone—ankylosing spondylitis	0.00971	0.0308	CrCrCtD
Danazol—Hydrocortisone—Dexamethasone—ankylosing spondylitis	0.00956	0.0303	CrCrCtD
Danazol—Hydrocortisone—Betamethasone—ankylosing spondylitis	0.00956	0.0303	CrCrCtD
Danazol—Hydrocortisone—Triamcinolone—ankylosing spondylitis	0.00934	0.0296	CrCrCtD
Danazol—Testosterone—Prednisolone—ankylosing spondylitis	0.00921	0.0292	CrCrCtD
Danazol—Hydrocortisone—Prednisone—ankylosing spondylitis	0.00887	0.0281	CrCrCtD
Danazol—Hydrocortisone—Prednisolone—ankylosing spondylitis	0.00865	0.0274	CrCrCtD
Danazol—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.00778	0.0376	CbGbCtD
Danazol—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0059	0.0285	CbGbCtD
Danazol—CYP3A4—Betamethasone—ankylosing spondylitis	0.00506	0.0245	CbGbCtD
Danazol—CYP3A4—Prednisolone—ankylosing spondylitis	0.00499	0.0241	CbGbCtD
Danazol—CYP3A4—Prednisone—ankylosing spondylitis	0.00472	0.0228	CbGbCtD
Danazol—CCL2—skeletal joint—ankylosing spondylitis	0.00416	0.52	CbGeAlD
Danazol—CCL2—synovial membrane of synovial joint—ankylosing spondylitis	0.00316	0.395	CbGeAlD
Danazol—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00294	0.0142	CbGbCtD
Danazol—CCL2—IL23-mediated signaling events—IL23R—ankylosing spondylitis	0.00154	0.163	CbGpPWpGaD
Danazol—PGR—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.00134	0.143	CbGpPWpGaD
Danazol—CCL2—IL23-mediated signaling events—IL17A—ankylosing spondylitis	0.000612	0.0651	CbGpPWpGaD
Danazol—CCL2—IL23-mediated signaling events—IL12B—ankylosing spondylitis	0.000569	0.0605	CbGpPWpGaD
Danazol—CCL2—tendon—ankylosing spondylitis	0.000478	0.0598	CbGeAlD
Danazol—CCL2—TNF alpha Signaling Pathway—TNFRSF1B—ankylosing spondylitis	0.000331	0.0352	CbGpPWpGaD
Danazol—CCL2—IL-1 signaling pathway—IL1A—ankylosing spondylitis	0.000305	0.0324	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—MMP3—ankylosing spondylitis	0.000282	0.03	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.000271	0.0288	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—IL10—ankylosing spondylitis	0.00025	0.0266	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—HLA-A—ankylosing spondylitis	0.00022	0.0234	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—CRP—ankylosing spondylitis	0.00022	0.0234	CbGpPWpGaD
Danazol—Interstitial lung disease—Methotrexate—ankylosing spondylitis	0.000209	0.00539	CcSEcCtD
Danazol—Amenorrhoea—Prednisone—ankylosing spondylitis	0.000202	0.0052	CcSEcCtD
Danazol—AR—tendon—ankylosing spondylitis	0.0002	0.025	CbGeAlD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—ankylosing spondylitis	0.000198	0.021	CbGpPWpGaD
Danazol—Fluid retention—Dexamethasone—ankylosing spondylitis	0.000193	0.00498	CcSEcCtD
Danazol—Fluid retention—Betamethasone—ankylosing spondylitis	0.000193	0.00498	CcSEcCtD
Danazol—Leukocytosis—Prednisone—ankylosing spondylitis	0.000189	0.00486	CcSEcCtD
Danazol—Visual disturbance—Prednisolone—ankylosing spondylitis	0.000187	0.00482	CcSEcCtD
Danazol—Cataract—Prednisone—ankylosing spondylitis	0.000186	0.0048	CcSEcCtD
Danazol—CCL2—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000175	0.0186	CbGpPWpGaD
Danazol—Affect lability—Prednisolone—ankylosing spondylitis	0.000174	0.00449	CcSEcCtD
Danazol—Fluid retention—Prednisone—ankylosing spondylitis	0.000168	0.00434	CcSEcCtD
Danazol—Mood swings—Prednisolone—ankylosing spondylitis	0.000168	0.00432	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—IL1A—ankylosing spondylitis	0.000165	0.0176	CbGpPWpGaD
Danazol—Affect lability—Triamcinolone—ankylosing spondylitis	0.00016	0.00413	CcSEcCtD
Danazol—Affect lability—Methylprednisolone—ankylosing spondylitis	0.00016	0.00412	CcSEcCtD
Danazol—CCL2—IL23-mediated signaling events—TNF—ankylosing spondylitis	0.000158	0.0168	CbGpPWpGaD
Danazol—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.000156	0.00402	CcSEcCtD
Danazol—Visual disturbance—Betamethasone—ankylosing spondylitis	0.000156	0.00402	CcSEcCtD
Danazol—Irritability—Methylprednisolone—ankylosing spondylitis	0.000155	0.004	CcSEcCtD
Danazol—Mood swings—Triamcinolone—ankylosing spondylitis	0.000154	0.00398	CcSEcCtD
Danazol—Mood swings—Methylprednisolone—ankylosing spondylitis	0.000154	0.00397	CcSEcCtD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX3—ankylosing spondylitis	0.000152	0.0162	CbGpPWpGaD
Danazol—Pancreatitis—Prednisolone—ankylosing spondylitis	0.00015	0.00387	CcSEcCtD
Danazol—Affect lability—Betamethasone—ankylosing spondylitis	0.000146	0.00375	CcSEcCtD
Danazol—Migraine—Betamethasone—ankylosing spondylitis	0.000146	0.00375	CcSEcCtD
Danazol—Affect lability—Dexamethasone—ankylosing spondylitis	0.000146	0.00375	CcSEcCtD
Danazol—Migraine—Dexamethasone—ankylosing spondylitis	0.000146	0.00375	CcSEcCtD
Danazol—CCL2—TWEAK Signaling Pathway—TNF—ankylosing spondylitis	0.000143	0.0152	CbGpPWpGaD
Danazol—Irritability—Betamethasone—ankylosing spondylitis	0.000141	0.00363	CcSEcCtD
Danazol—Irritability—Dexamethasone—ankylosing spondylitis	0.000141	0.00363	CcSEcCtD
Danazol—Mood swings—Betamethasone—ankylosing spondylitis	0.00014	0.00361	CcSEcCtD
Danazol—Mood swings—Dexamethasone—ankylosing spondylitis	0.00014	0.00361	CcSEcCtD
Danazol—Weight increased—Prednisolone—ankylosing spondylitis	0.000139	0.00359	CcSEcCtD
Danazol—PGR—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.000138	0.0147	CbGpPWpGaD
Danazol—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.000138	0.00356	CcSEcCtD
Danazol—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.000138	0.00355	CcSEcCtD
Danazol—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.000135	0.00347	CcSEcCtD
Danazol—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.000134	0.00345	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—TLR4—ankylosing spondylitis	0.000133	0.0141	CbGpPWpGaD
Danazol—Weight increased—Triamcinolone—ankylosing spondylitis	0.000128	0.0033	CcSEcCtD
Danazol—Weight increased—Methylprednisolone—ankylosing spondylitis	0.000128	0.00329	CcSEcCtD
Danazol—Affect lability—Prednisone—ankylosing spondylitis	0.000127	0.00326	CcSEcCtD
Danazol—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.000124	0.00319	CcSEcCtD
Danazol—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.000124	0.00318	CcSEcCtD
Danazol—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000123	0.00317	CcSEcCtD
Danazol—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.000123	0.00317	CcSEcCtD
Danazol—Irritability—Prednisone—ankylosing spondylitis	0.000123	0.00316	CcSEcCtD
Danazol—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.000123	0.00316	CcSEcCtD
Danazol—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000123	0.00316	CcSEcCtD
Danazol—Photosensitivity—Methotrexate—ankylosing spondylitis	0.000123	0.00316	CcSEcCtD
Danazol—CCL2—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.000123	0.013	CbGpPWpGaD
Danazol—Mood swings—Prednisone—ankylosing spondylitis	0.000122	0.00314	CcSEcCtD
Danazol—Sweating—Methylprednisolone—ankylosing spondylitis	0.00012	0.00309	CcSEcCtD
Danazol—Visual impairment—Prednisolone—ankylosing spondylitis	0.000118	0.00304	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.000117	0.0124	CbGpPWpGaD
Danazol—Weight increased—Betamethasone—ankylosing spondylitis	0.000116	0.00299	CcSEcCtD
Danazol—Weight increased—Dexamethasone—ankylosing spondylitis	0.000116	0.00299	CcSEcCtD
Danazol—Visual disturbance—Methotrexate—ankylosing spondylitis	0.000114	0.00292	CcSEcCtD
Danazol—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000113	0.00292	CcSEcCtD
Danazol—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000113	0.00291	CcSEcCtD
Danazol—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000113	0.0029	CcSEcCtD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000113	0.012	CbGpPWpGaD
Danazol—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000112	0.0029	CcSEcCtD
Danazol—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000112	0.00289	CcSEcCtD
Danazol—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000112	0.00289	CcSEcCtD
Danazol—ESR1—Leptin signaling pathway—IL1RN—ankylosing spondylitis	0.000112	0.0119	CbGpPWpGaD
Danazol—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000112	0.00288	CcSEcCtD
Danazol—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000112	0.00288	CcSEcCtD
Danazol—Pancreatitis—Prednisone—ankylosing spondylitis	0.000109	0.00281	CcSEcCtD
Danazol—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000108	0.00279	CcSEcCtD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000103	0.0109	CbGpPWpGaD
Danazol—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000103	0.00265	CcSEcCtD
Danazol—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000103	0.00265	CcSEcCtD
Danazol—Irritability—Methotrexate—ankylosing spondylitis	0.000103	0.00264	CcSEcCtD
Danazol—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000102	0.00263	CcSEcCtD
Danazol—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000102	0.00263	CcSEcCtD
Danazol—Mood swings—Methotrexate—ankylosing spondylitis	0.000102	0.00263	CcSEcCtD
Danazol—Weight increased—Prednisone—ankylosing spondylitis	0.000101	0.00261	CcSEcCtD
Danazol—Vision blurred—Prednisolone—ankylosing spondylitis	0.000101	0.00259	CcSEcCtD
Danazol—CCL2—Folate Metabolism—TNF—ankylosing spondylitis	9.97e-05	0.0106	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	9.91e-05	0.0105	CbGpPWpGaD
Danazol—Visual impairment—Dexamethasone—ankylosing spondylitis	9.86e-05	0.00254	CcSEcCtD
Danazol—Visual impairment—Betamethasone—ankylosing spondylitis	9.86e-05	0.00254	CcSEcCtD
Danazol—Acute coronary syndrome—Prednisone—ankylosing spondylitis	9.78e-05	0.00252	CcSEcCtD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—IL10—ankylosing spondylitis	9.77e-05	0.0104	CbGpPWpGaD
Danazol—Myocardial infarction—Prednisone—ankylosing spondylitis	9.73e-05	0.0025	CcSEcCtD
Danazol—Vertigo—Prednisolone—ankylosing spondylitis	9.59e-05	0.00247	CcSEcCtD
Danazol—Syncope—Prednisolone—ankylosing spondylitis	9.57e-05	0.00246	CcSEcCtD
Danazol—Back pain—Triamcinolone—ankylosing spondylitis	9.49e-05	0.00244	CcSEcCtD
Danazol—Loss of consciousness—Prednisolone—ankylosing spondylitis	9.38e-05	0.00242	CcSEcCtD
Danazol—Convulsion—Prednisolone—ankylosing spondylitis	9.25e-05	0.00238	CcSEcCtD
Danazol—Hypertension—Prednisolone—ankylosing spondylitis	9.21e-05	0.00237	CcSEcCtD
Danazol—Eosinophilia—Methotrexate—ankylosing spondylitis	9.21e-05	0.00237	CcSEcCtD
Danazol—Pancreatitis—Methotrexate—ankylosing spondylitis	9.12e-05	0.00235	CcSEcCtD
Danazol—Alopecia—Betamethasone—ankylosing spondylitis	9.04e-05	0.00233	CcSEcCtD
Danazol—Alopecia—Dexamethasone—ankylosing spondylitis	9.04e-05	0.00233	CcSEcCtD
Danazol—Haemoglobin—Prednisone—ankylosing spondylitis	8.95e-05	0.00231	CcSEcCtD
Danazol—Haemorrhage—Prednisone—ankylosing spondylitis	8.91e-05	0.00229	CcSEcCtD
Danazol—Vertigo—Triamcinolone—ankylosing spondylitis	8.82e-05	0.00227	CcSEcCtD
Danazol—Syncope—Triamcinolone—ankylosing spondylitis	8.8e-05	0.00227	CcSEcCtD
Danazol—Vertigo—Methylprednisolone—ankylosing spondylitis	8.8e-05	0.00227	CcSEcCtD
Danazol—CCL2—Metabolism of proteins—B3GNT2—ankylosing spondylitis	8.8e-05	0.00935	CbGpPWpGaD
Danazol—Syncope—Methylprednisolone—ankylosing spondylitis	8.78e-05	0.00226	CcSEcCtD
Danazol—Oedema—Prednisolone—ankylosing spondylitis	8.71e-05	0.00224	CcSEcCtD
Danazol—Loss of consciousness—Triamcinolone—ankylosing spondylitis	8.63e-05	0.00222	CcSEcCtD
Danazol—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	8.61e-05	0.00222	CcSEcCtD
Danazol—CCL2—GPCR ligand binding—PTGER4—ankylosing spondylitis	8.58e-05	0.00912	CbGpPWpGaD
Danazol—Shock—Prednisolone—ankylosing spondylitis	8.57e-05	0.00221	CcSEcCtD
Danazol—Convulsion—Triamcinolone—ankylosing spondylitis	8.5e-05	0.00219	CcSEcCtD
Danazol—Tachycardia—Prednisolone—ankylosing spondylitis	8.5e-05	0.00219	CcSEcCtD
Danazol—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	8.49e-05	0.00219	CcSEcCtD
Danazol—Convulsion—Methylprednisolone—ankylosing spondylitis	8.48e-05	0.00218	CcSEcCtD
Danazol—Hypertension—Triamcinolone—ankylosing spondylitis	8.47e-05	0.00218	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—IL10—ankylosing spondylitis	8.46e-05	0.00899	CbGpPWpGaD
Danazol—Hypertension—Methylprednisolone—ankylosing spondylitis	8.45e-05	0.00218	CcSEcCtD
Danazol—Hyperhidrosis—Prednisolone—ankylosing spondylitis	8.42e-05	0.00217	CcSEcCtD
Danazol—Arthralgia—Methylprednisolone—ankylosing spondylitis	8.34e-05	0.00215	CcSEcCtD
Danazol—Anxiety—Methylprednisolone—ankylosing spondylitis	8.31e-05	0.00214	CcSEcCtD
Danazol—Flushing—Prednisone—ankylosing spondylitis	8.27e-05	0.00213	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	8.22e-05	0.00212	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	8.08e-05	0.00859	CbGpPWpGaD
Danazol—Oedema—Triamcinolone—ankylosing spondylitis	8.01e-05	0.00206	CcSEcCtD
Danazol—Vertigo—Dexamethasone—ankylosing spondylitis	8e-05	0.00206	CcSEcCtD
Danazol—Vertigo—Betamethasone—ankylosing spondylitis	8e-05	0.00206	CcSEcCtD
Danazol—Syncope—Dexamethasone—ankylosing spondylitis	7.99e-05	0.00206	CcSEcCtD
Danazol—Syncope—Betamethasone—ankylosing spondylitis	7.99e-05	0.00206	CcSEcCtD
Danazol—Sweating—Methotrexate—ankylosing spondylitis	7.95e-05	0.00205	CcSEcCtD
Danazol—CCL2—Selenium Micronutrient Network—TNF—ankylosing spondylitis	7.92e-05	0.00842	CbGpPWpGaD
Danazol—Haematuria—Methotrexate—ankylosing spondylitis	7.91e-05	0.00204	CcSEcCtD
Danazol—Shock—Triamcinolone—ankylosing spondylitis	7.88e-05	0.00203	CcSEcCtD
Danazol—Alopecia—Prednisone—ankylosing spondylitis	7.87e-05	0.00203	CcSEcCtD
Danazol—Shock—Methylprednisolone—ankylosing spondylitis	7.86e-05	0.00202	CcSEcCtD
Danazol—GNRHR—GPCR ligand binding—PTGER4—ankylosing spondylitis	7.84e-05	0.00834	CbGpPWpGaD
Danazol—Loss of consciousness—Betamethasone—ankylosing spondylitis	7.83e-05	0.00202	CcSEcCtD
Danazol—Loss of consciousness—Dexamethasone—ankylosing spondylitis	7.83e-05	0.00202	CcSEcCtD
Danazol—Paraesthesia—Prednisolone—ankylosing spondylitis	7.82e-05	0.00201	CcSEcCtD
Danazol—Tachycardia—Triamcinolone—ankylosing spondylitis	7.82e-05	0.00201	CcSEcCtD
Danazol—Tachycardia—Methylprednisolone—ankylosing spondylitis	7.8e-05	0.00201	CcSEcCtD
Danazol—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	7.74e-05	0.00199	CcSEcCtD
Danazol—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	7.73e-05	0.00199	CcSEcCtD
Danazol—Convulsion—Dexamethasone—ankylosing spondylitis	7.72e-05	0.00199	CcSEcCtD
Danazol—Convulsion—Betamethasone—ankylosing spondylitis	7.72e-05	0.00199	CcSEcCtD
Danazol—Hypertension—Dexamethasone—ankylosing spondylitis	7.69e-05	0.00198	CcSEcCtD
Danazol—Hypertension—Betamethasone—ankylosing spondylitis	7.69e-05	0.00198	CcSEcCtD
Danazol—CCL2—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	7.64e-05	0.00812	CbGpPWpGaD
Danazol—Anxiety—Betamethasone—ankylosing spondylitis	7.55e-05	0.00195	CcSEcCtD
Danazol—Anxiety—Dexamethasone—ankylosing spondylitis	7.55e-05	0.00195	CcSEcCtD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—ankylosing spondylitis	7.53e-05	0.008	CbGpPWpGaD
Danazol—Haemoglobin—Methotrexate—ankylosing spondylitis	7.48e-05	0.00193	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—HLA-A—ankylosing spondylitis	7.45e-05	0.00792	CbGpPWpGaD
Danazol—Haemorrhage—Methotrexate—ankylosing spondylitis	7.44e-05	0.00192	CcSEcCtD
Danazol—Vision blurred—Prednisone—ankylosing spondylitis	7.31e-05	0.00188	CcSEcCtD
Danazol—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	7.3e-05	0.00188	CcSEcCtD
Danazol—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	7.28e-05	0.00187	CcSEcCtD
Danazol—Oedema—Betamethasone—ankylosing spondylitis	7.27e-05	0.00187	CcSEcCtD
Danazol—Oedema—Dexamethasone—ankylosing spondylitis	7.27e-05	0.00187	CcSEcCtD
Danazol—Paraesthesia—Triamcinolone—ankylosing spondylitis	7.19e-05	0.00185	CcSEcCtD
Danazol—Paraesthesia—Methylprednisolone—ankylosing spondylitis	7.18e-05	0.00185	CcSEcCtD
Danazol—Visual impairment—Methotrexate—ankylosing spondylitis	7.17e-05	0.00185	CcSEcCtD
Danazol—Shock—Dexamethasone—ankylosing spondylitis	7.15e-05	0.00184	CcSEcCtD
Danazol—Shock—Betamethasone—ankylosing spondylitis	7.15e-05	0.00184	CcSEcCtD
Danazol—Thrombocytopenia—Betamethasone—ankylosing spondylitis	7.12e-05	0.00183	CcSEcCtD
Danazol—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	7.12e-05	0.00183	CcSEcCtD
Danazol—Tachycardia—Betamethasone—ankylosing spondylitis	7.09e-05	0.00183	CcSEcCtD
Danazol—Tachycardia—Dexamethasone—ankylosing spondylitis	7.09e-05	0.00183	CcSEcCtD
Danazol—Dyspepsia—Triamcinolone—ankylosing spondylitis	7.05e-05	0.00182	CcSEcCtD
Danazol—Erythema multiforme—Methotrexate—ankylosing spondylitis	7.04e-05	0.00181	CcSEcCtD
Danazol—Dyspepsia—Methylprednisolone—ankylosing spondylitis	7.03e-05	0.00181	CcSEcCtD
Danazol—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	7.03e-05	0.00181	CcSEcCtD
Danazol—Hyperhidrosis—Betamethasone—ankylosing spondylitis	7.03e-05	0.00181	CcSEcCtD
Danazol—Vertigo—Prednisone—ankylosing spondylitis	6.97e-05	0.00179	CcSEcCtD
Danazol—Syncope—Prednisone—ankylosing spondylitis	6.95e-05	0.00179	CcSEcCtD
Danazol—Urticaria—Prednisolone—ankylosing spondylitis	6.92e-05	0.00178	CcSEcCtD
Danazol—Fatigue—Triamcinolone—ankylosing spondylitis	6.91e-05	0.00178	CcSEcCtD
Danazol—Fatigue—Methylprednisolone—ankylosing spondylitis	6.89e-05	0.00177	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Betamethasone—ankylosing spondylitis	6.83e-05	0.0236	CbGdCrCtD
Danazol—CCL2—Methylprednisolone—Dexamethasone—ankylosing spondylitis	6.83e-05	0.0236	CbGdCrCtD
Danazol—Loss of consciousness—Prednisone—ankylosing spondylitis	6.82e-05	0.00176	CcSEcCtD
Danazol—Convulsion—Prednisone—ankylosing spondylitis	6.72e-05	0.00173	CcSEcCtD
Danazol—Hypertension—Prednisone—ankylosing spondylitis	6.7e-05	0.00172	CcSEcCtD
Danazol—Chills—Methotrexate—ankylosing spondylitis	6.68e-05	0.00172	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Triamcinolone—ankylosing spondylitis	6.68e-05	0.023	CbGdCrCtD
Danazol—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	6.62e-05	0.0017	CcSEcCtD
Danazol—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	6.62e-05	0.0017	CcSEcCtD
Danazol—Arthralgia—Prednisone—ankylosing spondylitis	6.6e-05	0.0017	CcSEcCtD
Danazol—Anxiety—Prednisone—ankylosing spondylitis	6.58e-05	0.00169	CcSEcCtD
Danazol—Alopecia—Methotrexate—ankylosing spondylitis	6.58e-05	0.00169	CcSEcCtD
Danazol—Paraesthesia—Betamethasone—ankylosing spondylitis	6.53e-05	0.00168	CcSEcCtD
Danazol—Paraesthesia—Dexamethasone—ankylosing spondylitis	6.53e-05	0.00168	CcSEcCtD
Danazol—Dyspepsia—Betamethasone—ankylosing spondylitis	6.4e-05	0.00165	CcSEcCtD
Danazol—Dyspepsia—Dexamethasone—ankylosing spondylitis	6.4e-05	0.00165	CcSEcCtD
Danazol—Urticaria—Triamcinolone—ankylosing spondylitis	6.36e-05	0.00164	CcSEcCtD
Danazol—Urticaria—Methylprednisolone—ankylosing spondylitis	6.35e-05	0.00163	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Prednisone—ankylosing spondylitis	6.34e-05	0.0219	CbGdCrCtD
Danazol—Body temperature increased—Triamcinolone—ankylosing spondylitis	6.33e-05	0.00163	CcSEcCtD
Danazol—Oedema—Prednisone—ankylosing spondylitis	6.33e-05	0.00163	CcSEcCtD
Danazol—Back pain—Methotrexate—ankylosing spondylitis	6.27e-05	0.00161	CcSEcCtD
Danazol—Fatigue—Dexamethasone—ankylosing spondylitis	6.27e-05	0.00161	CcSEcCtD
Danazol—Fatigue—Betamethasone—ankylosing spondylitis	6.27e-05	0.00161	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—TNF—ankylosing spondylitis	6.26e-05	0.00666	CbGpPWpGaD
Danazol—Shock—Prednisone—ankylosing spondylitis	6.23e-05	0.0016	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Prednisolone—ankylosing spondylitis	6.18e-05	0.0213	CbGdCrCtD
Danazol—Tachycardia—Prednisone—ankylosing spondylitis	6.18e-05	0.00159	CcSEcCtD
Danazol—CCL2—Beclomethasone—Betamethasone—ankylosing spondylitis	6.13e-05	0.0211	CbGdCrCtD
Danazol—CCL2—Beclomethasone—Dexamethasone—ankylosing spondylitis	6.13e-05	0.0211	CbGdCrCtD
Danazol—Hyperhidrosis—Prednisone—ankylosing spondylitis	6.12e-05	0.00158	CcSEcCtD
Danazol—Vision blurred—Methotrexate—ankylosing spondylitis	6.11e-05	0.00157	CcSEcCtD
Danazol—CCL2—Beclomethasone—Triamcinolone—ankylosing spondylitis	5.99e-05	0.0207	CbGdCrCtD
Danazol—Vertigo—Methotrexate—ankylosing spondylitis	5.82e-05	0.0015	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	5.82e-05	0.00618	CbGpPWpGaD
Danazol—Leukopenia—Methotrexate—ankylosing spondylitis	5.8e-05	0.00149	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	5.78e-05	0.00615	CbGpPWpGaD
Danazol—Urticaria—Betamethasone—ankylosing spondylitis	5.77e-05	0.00149	CcSEcCtD
Danazol—Urticaria—Dexamethasone—ankylosing spondylitis	5.77e-05	0.00149	CcSEcCtD
Danazol—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	5.77e-05	0.00148	CcSEcCtD
Danazol—Dizziness—Prednisolone—ankylosing spondylitis	5.76e-05	0.00148	CcSEcCtD
Danazol—Asthenia—Triamcinolone—ankylosing spondylitis	5.75e-05	0.00148	CcSEcCtD
Danazol—Body temperature increased—Betamethasone—ankylosing spondylitis	5.74e-05	0.00148	CcSEcCtD
Danazol—Body temperature increased—Dexamethasone—ankylosing spondylitis	5.74e-05	0.00148	CcSEcCtD
Danazol—CCL2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	5.74e-05	0.0198	CbGdCrCtD
Danazol—Asthenia—Methylprednisolone—ankylosing spondylitis	5.73e-05	0.00148	CcSEcCtD
Danazol—Paraesthesia—Prednisone—ankylosing spondylitis	5.68e-05	0.00146	CcSEcCtD
Danazol—Pruritus—Triamcinolone—ankylosing spondylitis	5.67e-05	0.00146	CcSEcCtD
Danazol—CCL2—Fluocinonide—Betamethasone—ankylosing spondylitis	5.65e-05	0.0195	CbGdCrCtD
Danazol—CCL2—Fluocinonide—Dexamethasone—ankylosing spondylitis	5.65e-05	0.0195	CbGdCrCtD
Danazol—Pruritus—Methylprednisolone—ankylosing spondylitis	5.65e-05	0.00146	CcSEcCtD
Danazol—Convulsion—Methotrexate—ankylosing spondylitis	5.62e-05	0.00145	CcSEcCtD
Danazol—Dyspepsia—Prednisone—ankylosing spondylitis	5.57e-05	0.00143	CcSEcCtD
Danazol—CCL2—Beclomethasone—Prednisolone—ankylosing spondylitis	5.55e-05	0.0191	CbGdCrCtD
Danazol—CCL2—Fluocinonide—Triamcinolone—ankylosing spondylitis	5.52e-05	0.0191	CbGdCrCtD
Danazol—Arthralgia—Methotrexate—ankylosing spondylitis	5.52e-05	0.00142	CcSEcCtD
Danazol—Rash—Prednisolone—ankylosing spondylitis	5.49e-05	0.00141	CcSEcCtD
Danazol—Dermatitis—Prednisolone—ankylosing spondylitis	5.49e-05	0.00141	CcSEcCtD
Danazol—Fatigue—Prednisone—ankylosing spondylitis	5.46e-05	0.00141	CcSEcCtD
Danazol—Headache—Prednisolone—ankylosing spondylitis	5.46e-05	0.0014	CcSEcCtD
Danazol—CCL2—Amcinonide—Dexamethasone—ankylosing spondylitis	5.42e-05	0.0187	CbGdCrCtD
Danazol—CCL2—Amcinonide—Betamethasone—ankylosing spondylitis	5.42e-05	0.0187	CbGdCrCtD
Danazol—Constipation—Prednisone—ankylosing spondylitis	5.41e-05	0.00139	CcSEcCtD
Danazol—CCL2—Amcinonide—Triamcinolone—ankylosing spondylitis	5.3e-05	0.0183	CbGdCrCtD
Danazol—Dizziness—Triamcinolone—ankylosing spondylitis	5.3e-05	0.00136	CcSEcCtD
Danazol—Dizziness—Methylprednisolone—ankylosing spondylitis	5.28e-05	0.00136	CcSEcCtD
Danazol—Asthenia—Betamethasone—ankylosing spondylitis	5.21e-05	0.00134	CcSEcCtD
Danazol—Asthenia—Dexamethasone—ankylosing spondylitis	5.21e-05	0.00134	CcSEcCtD
Danazol—Thrombocytopenia—Methotrexate—ankylosing spondylitis	5.18e-05	0.00133	CcSEcCtD
Danazol—Nausea—Prednisolone—ankylosing spondylitis	5.17e-05	0.00133	CcSEcCtD
Danazol—Pruritus—Betamethasone—ankylosing spondylitis	5.14e-05	0.00132	CcSEcCtD
Danazol—Pruritus—Dexamethasone—ankylosing spondylitis	5.14e-05	0.00132	CcSEcCtD
Danazol—Hyperhidrosis—Methotrexate—ankylosing spondylitis	5.11e-05	0.00132	CcSEcCtD
Danazol—Vomiting—Triamcinolone—ankylosing spondylitis	5.09e-05	0.00131	CcSEcCtD
Danazol—Vomiting—Methylprednisolone—ankylosing spondylitis	5.08e-05	0.00131	CcSEcCtD
Danazol—Rash—Triamcinolone—ankylosing spondylitis	5.05e-05	0.0013	CcSEcCtD
Danazol—Dermatitis—Triamcinolone—ankylosing spondylitis	5.05e-05	0.0013	CcSEcCtD
Danazol—Rash—Methylprednisolone—ankylosing spondylitis	5.04e-05	0.0013	CcSEcCtD
Danazol—Dermatitis—Methylprednisolone—ankylosing spondylitis	5.03e-05	0.0013	CcSEcCtD
Danazol—Urticaria—Prednisone—ankylosing spondylitis	5.03e-05	0.00129	CcSEcCtD
Danazol—CCL2—Amcinonide—Prednisone—ankylosing spondylitis	5.03e-05	0.0173	CbGdCrCtD
Danazol—Headache—Triamcinolone—ankylosing spondylitis	5.02e-05	0.00129	CcSEcCtD
Danazol—Headache—Methylprednisolone—ankylosing spondylitis	5.01e-05	0.00129	CcSEcCtD
Danazol—Body temperature increased—Prednisone—ankylosing spondylitis	5e-05	0.00129	CcSEcCtD
Danazol—CCL2—Amcinonide—Prednisolone—ankylosing spondylitis	4.91e-05	0.0169	CbGdCrCtD
Danazol—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	4.82e-05	0.00124	CcSEcCtD
Danazol—Dizziness—Betamethasone—ankylosing spondylitis	4.81e-05	0.00124	CcSEcCtD
Danazol—Dizziness—Dexamethasone—ankylosing spondylitis	4.81e-05	0.00124	CcSEcCtD
Danazol—Nausea—Triamcinolone—ankylosing spondylitis	4.76e-05	0.00123	CcSEcCtD
Danazol—Paraesthesia—Methotrexate—ankylosing spondylitis	4.75e-05	0.00122	CcSEcCtD
Danazol—Nausea—Methylprednisolone—ankylosing spondylitis	4.75e-05	0.00122	CcSEcCtD
Danazol—Dyspepsia—Methotrexate—ankylosing spondylitis	4.66e-05	0.0012	CcSEcCtD
Danazol—Vomiting—Dexamethasone—ankylosing spondylitis	4.62e-05	0.00119	CcSEcCtD
Danazol—Vomiting—Betamethasone—ankylosing spondylitis	4.62e-05	0.00119	CcSEcCtD
Danazol—Rash—Betamethasone—ankylosing spondylitis	4.58e-05	0.00118	CcSEcCtD
Danazol—Rash—Dexamethasone—ankylosing spondylitis	4.58e-05	0.00118	CcSEcCtD
Danazol—Dermatitis—Dexamethasone—ankylosing spondylitis	4.58e-05	0.00118	CcSEcCtD
Danazol—Dermatitis—Betamethasone—ankylosing spondylitis	4.58e-05	0.00118	CcSEcCtD
Danazol—Fatigue—Methotrexate—ankylosing spondylitis	4.56e-05	0.00117	CcSEcCtD
Danazol—Headache—Dexamethasone—ankylosing spondylitis	4.55e-05	0.00117	CcSEcCtD
Danazol—Headache—Betamethasone—ankylosing spondylitis	4.55e-05	0.00117	CcSEcCtD
Danazol—Asthenia—Prednisone—ankylosing spondylitis	4.54e-05	0.00117	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	4.5e-05	0.00479	CbGpPWpGaD
Danazol—Pruritus—Prednisone—ankylosing spondylitis	4.48e-05	0.00115	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—PTGER4—ankylosing spondylitis	4.43e-05	0.00471	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—PTGER4—ankylosing spondylitis	4.4e-05	0.00468	CbGpPWpGaD
Danazol—Nausea—Dexamethasone—ankylosing spondylitis	4.32e-05	0.00111	CcSEcCtD
Danazol—Nausea—Betamethasone—ankylosing spondylitis	4.32e-05	0.00111	CcSEcCtD
Danazol—CCL2—Fluorometholone—Methylprednisolone—ankylosing spondylitis	4.3e-05	0.0148	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Methylprednisolone—ankylosing spondylitis	4.28e-05	0.0148	CbGdCrCtD
Danazol—CCL2—Fluorometholone—Dexamethasone—ankylosing spondylitis	4.23e-05	0.0146	CbGdCrCtD
Danazol—CCL2—Fluorometholone—Betamethasone—ankylosing spondylitis	4.23e-05	0.0146	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Betamethasone—ankylosing spondylitis	4.21e-05	0.0145	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Dexamethasone—ankylosing spondylitis	4.21e-05	0.0145	CbGdCrCtD
Danazol—Urticaria—Methotrexate—ankylosing spondylitis	4.2e-05	0.00108	CcSEcCtD
Danazol—Dizziness—Prednisone—ankylosing spondylitis	4.19e-05	0.00108	CcSEcCtD
Danazol—Body temperature increased—Methotrexate—ankylosing spondylitis	4.18e-05	0.00108	CcSEcCtD
Danazol—CCL2—Fluorometholone—Triamcinolone—ankylosing spondylitis	4.14e-05	0.0143	CbGdCrCtD
Danazol—GNRHR—Signaling by GPCR—PTGER4—ankylosing spondylitis	4.03e-05	0.00428	CbGpPWpGaD
Danazol—Vomiting—Prednisone—ankylosing spondylitis	4.02e-05	0.00104	CcSEcCtD
Danazol—Rash—Prednisone—ankylosing spondylitis	3.99e-05	0.00103	CcSEcCtD
Danazol—Dermatitis—Prednisone—ankylosing spondylitis	3.99e-05	0.00103	CcSEcCtD
Danazol—Headache—Prednisone—ankylosing spondylitis	3.96e-05	0.00102	CcSEcCtD
Danazol—CCL2—Fluorometholone—Prednisone—ankylosing spondylitis	3.93e-05	0.0135	CbGdCrCtD
Danazol—CCL2—Fluorometholone—Prednisolone—ankylosing spondylitis	3.83e-05	0.0132	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Prednisolone—ankylosing spondylitis	3.81e-05	0.0131	CbGdCrCtD
Danazol—Asthenia—Methotrexate—ankylosing spondylitis	3.79e-05	0.000977	CcSEcCtD
Danazol—Nausea—Prednisone—ankylosing spondylitis	3.76e-05	0.000968	CcSEcCtD
Danazol—Pruritus—Methotrexate—ankylosing spondylitis	3.74e-05	0.000964	CcSEcCtD
Danazol—CCL2—Clobetasol propionate—Methylprednisolone—ankylosing spondylitis	3.64e-05	0.0126	CbGdCrCtD
Danazol—CCL2—Flunisolide—Methylprednisolone—ankylosing spondylitis	3.59e-05	0.0124	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Betamethasone—ankylosing spondylitis	3.58e-05	0.0124	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Dexamethasone—ankylosing spondylitis	3.58e-05	0.0124	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Methylprednisolone—ankylosing spondylitis	3.55e-05	0.0123	CbGdCrCtD
Danazol—CCL2—Flunisolide—Dexamethasone—ankylosing spondylitis	3.53e-05	0.0122	CbGdCrCtD
Danazol—CCL2—Flunisolide—Betamethasone—ankylosing spondylitis	3.53e-05	0.0122	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Triamcinolone—ankylosing spondylitis	3.5e-05	0.0121	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Betamethasone—ankylosing spondylitis	3.5e-05	0.0121	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Dexamethasone—ankylosing spondylitis	3.5e-05	0.0121	CbGdCrCtD
Danazol—Dizziness—Methotrexate—ankylosing spondylitis	3.5e-05	0.000901	CcSEcCtD
Danazol—CCL2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	3.47e-05	0.012	CbGdCrCtD
Danazol—CCL2—Flunisolide—Triamcinolone—ankylosing spondylitis	3.45e-05	0.0119	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	3.41e-05	0.0118	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	3.41e-05	0.0118	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Methylprednisolone—ankylosing spondylitis	3.38e-05	0.0116	CbGdCrCtD
Danazol—Vomiting—Methotrexate—ankylosing spondylitis	3.36e-05	0.000866	CcSEcCtD
Danazol—Rash—Methotrexate—ankylosing spondylitis	3.33e-05	0.000859	CcSEcCtD
Danazol—CCL2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	3.33e-05	0.0115	CbGdCrCtD
Danazol—Dermatitis—Methotrexate—ankylosing spondylitis	3.33e-05	0.000858	CcSEcCtD
Danazol—CCL2—Desoximetasone—Betamethasone—ankylosing spondylitis	3.32e-05	0.0115	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Dexamethasone—ankylosing spondylitis	3.32e-05	0.0115	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Prednisone—ankylosing spondylitis	3.32e-05	0.0115	CbGdCrCtD
Danazol—Headache—Methotrexate—ankylosing spondylitis	3.31e-05	0.000853	CcSEcCtD
Danazol—CCL2—Flunisolide—Prednisone—ankylosing spondylitis	3.28e-05	0.0113	CbGdCrCtD
Danazol—CCL2—Diflorasone—Methylprednisolone—ankylosing spondylitis	3.28e-05	0.0113	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Triamcinolone—ankylosing spondylitis	3.25e-05	0.0112	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Prednisone—ankylosing spondylitis	3.24e-05	0.0112	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Prednisolone—ankylosing spondylitis	3.24e-05	0.0112	CbGdCrCtD
Danazol—CCL2—Diflorasone—Dexamethasone—ankylosing spondylitis	3.22e-05	0.0111	CbGdCrCtD
Danazol—CCL2—Diflorasone—Betamethasone—ankylosing spondylitis	3.22e-05	0.0111	CbGdCrCtD
Danazol—CCL2—Flunisolide—Prednisolone—ankylosing spondylitis	3.2e-05	0.011	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Prednisolone—ankylosing spondylitis	3.17e-05	0.0109	CbGdCrCtD
Danazol—CCL2—Diflorasone—Triamcinolone—ankylosing spondylitis	3.15e-05	0.0109	CbGdCrCtD
Danazol—Nausea—Methotrexate—ankylosing spondylitis	3.14e-05	0.000809	CcSEcCtD
Danazol—CCL2—Signaling by GPCR—MMP3—ankylosing spondylitis	3.13e-05	0.00333	CbGpPWpGaD
Danazol—CCL2—Desoximetasone—Prednisone—ankylosing spondylitis	3.08e-05	0.0106	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Prednisolone—ankylosing spondylitis	3.01e-05	0.0104	CbGdCrCtD
Danazol—CCL2—Diflorasone—Prednisone—ankylosing spondylitis	2.99e-05	0.0103	CbGdCrCtD
Danazol—CCL2—Diflorasone—Prednisolone—ankylosing spondylitis	2.92e-05	0.0101	CbGdCrCtD
Danazol—CCL2—Budesonide—Methylprednisolone—ankylosing spondylitis	2.87e-05	0.00991	CbGdCrCtD
Danazol—GNRHR—Signaling by GPCR—MMP3—ankylosing spondylitis	2.87e-05	0.00305	CbGpPWpGaD
Danazol—CCL2—Budesonide—Dexamethasone—ankylosing spondylitis	2.83e-05	0.00975	CbGdCrCtD
Danazol—CCL2—Budesonide—Betamethasone—ankylosing spondylitis	2.83e-05	0.00975	CbGdCrCtD
Danazol—CCL2—Budesonide—Triamcinolone—ankylosing spondylitis	2.76e-05	0.00953	CbGdCrCtD
Danazol—CCL2—Budesonide—Prednisone—ankylosing spondylitis	2.62e-05	0.00904	CbGdCrCtD
Danazol—CCL2—Signaling Pathways—PTGER4—ankylosing spondylitis	2.6e-05	0.00276	CbGpPWpGaD
Danazol—CCL2—Budesonide—Prednisolone—ankylosing spondylitis	2.56e-05	0.00883	CbGdCrCtD
Danazol—GNRHR—Signaling Pathways—PTGER4—ankylosing spondylitis	2.38e-05	0.00253	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	2.2e-05	0.00234	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	1.87e-05	0.00199	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP3—ankylosing spondylitis	1.85e-05	0.00197	CbGpPWpGaD
Danazol—CCL2—Dexamethasone—Methylprednisolone—ankylosing spondylitis	1.76e-05	0.00606	CbGdCrCtD
Danazol—CCL2—Betamethasone—Methylprednisolone—ankylosing spondylitis	1.76e-05	0.00606	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Betamethasone—ankylosing spondylitis	1.73e-05	0.00597	CbGdCrCtD
Danazol—CCL2—Betamethasone—Dexamethasone—ankylosing spondylitis	1.73e-05	0.00597	CbGdCrCtD
Danazol—CYP19A1—Metabolism—B3GNT2—ankylosing spondylitis	1.71e-05	0.00182	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP3—ankylosing spondylitis	1.69e-05	0.0018	CbGpPWpGaD
Danazol—CCL2—Dexamethasone—Triamcinolone—ankylosing spondylitis	1.69e-05	0.00583	CbGdCrCtD
Danazol—CCL2—Betamethasone—Triamcinolone—ankylosing spondylitis	1.69e-05	0.00583	CbGdCrCtD
Danazol—CCL2—Betamethasone—Prednisone—ankylosing spondylitis	1.6e-05	0.00553	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Prednisone—ankylosing spondylitis	1.6e-05	0.00553	CbGdCrCtD
Danazol—CCL2—Betamethasone—Prednisolone—ankylosing spondylitis	1.57e-05	0.0054	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Prednisolone—ankylosing spondylitis	1.57e-05	0.0054	CbGdCrCtD
Danazol—PGR—Signaling Pathways—PTGER4—ankylosing spondylitis	1.5e-05	0.00159	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	1.44e-05	0.00153	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP3—ankylosing spondylitis	1.07e-05	0.00113	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTGER4—ankylosing spondylitis	8.8e-06	0.000936	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP3—ankylosing spondylitis	6.27e-06	0.000666	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	5e-06	0.000532	CbGpPWpGaD
